biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by darniton Jul 07, 2015 11:10am

61 Views

Post# 23898465

RE:RE:RE:RE:m&a 101..... or in this board's case, for dummies!

JD, give me one reason why you don't want the price to go down. Deals are in the wings, so wouldn't you welcome an opportunity to buy more stock at a cheaper price prior to a deal being announced? It's a simple question. Let's see if you can give a straight answer without sidestepping and accusing me of the usual insults.

Bullboard Posts

Southern Ontario mineral processing operation receives green fund support